FeaturesSignalPricingFounders
CM

CHL Medical Partners

Venture CapitalActive

CHL Medical Partners, an American venture capital firm, invests in biotechnology, molecular diagnostic, and medical device companies.

Stamford, United StatesFounded 2008chlmedical.com/
40
Investments
10
Exits
—
AUM
25.0%
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for CHL Medical Partners.

Get started free

Investment Thesis & Strategy

CHL Medical Partners invests in biotechnology, molecular diagnostic, and medical device companies across various stages of development. They seek companies with innovative solutions in the healthcare sector.

Investment Activity

Deals per year over the last 14 years

2
2005
0
2006
0
2007
0
2008
1
2009
0
2010
1
2011
1
2012
2
2013
0
2014
2
2015
0
2016
0
2017
2
2018

Portfolio Companies

Selected investments from their portfolio of 40 companies

N
Neurocrine Biosciences
Biotech · Series B, 0
Active
A
Aethon
Healthcare · Growth, 2018
Active
I
InCarda Therapeutics
Biotech · Series B, 2018
Active
L
Lantheus Holdings
Biotech · Growth, 2015
Active
C
Cerecor
Biotech · Series C+, 2015
Active
C
Concordia Healthcare
Healthcare · Growth, 2013
Active
B
Biocept
Biotech · Series C+, 2013
Active
D
Dermira
Biotech · Series B, 2012
Active
R
Radius Health
Biotech · Series B, 2011
Active
E
Exact Sciences
Biotech · Series B, 2009
Active
S
Sequenom
Biotech · Series B, 2005
Active
M
Medivation
Biotech · Series B, 2005
Active

Frequently Asked Questions

CHL Medical Partners focuses on Series A, Series B, Series C+ stage investments.

Related Investors

Thomas, McNerney & Partners

Stamford, United States · 46 deals

BEV Capital

Stamford, United States · 35 deals

GE Energy Financial Services

Stamford, United States · 19 deals

Hudson Structured Capital Management

Stamford, United States · 10 deals

TWJ Capital

Stamford, United States · 10 deals

Excelsior Venture Partners III

Stamford, United States · 10 deals